2016 annual financial data
Biodexa Pharmaceuticals 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -989.12%.
Operating income was -9,652,000 USD and net income was -6,161,000 USD.
Operating cash flow was -13,086,000 USD.
Get free Biodexa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,323,000 USD
- Operating income
- -9,652,000 USD
- Net income
- -6,161,000 USD
- Operating cash flow
- -13,086,000 USD